Concorde Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Concorde Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,868	Closed	-$615K	–	187
2018 Q3	$615K	Sell	15,868 -5,339	-25%	-$192K	0.6%	53
2018 Q2	$710K	Buy	21,207 +6,317	+42%	+$225K	0.81%	33
2018 Q1	$569K	Sell	14,890 -661	-4%	-$22.9K	0.7%	44
2017 Q4	$495K	Sell	15,551 -19,561	-56%	-$670K	0.63%	54
2017 Q3	$1.31M	Buy	35,112 +15,330	+77%	+$522K	1.14%	20
2017 Q2	$618K	Buy	+19,782	New	+$571K	0.83%	35

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Concorde Asset Management's LMAT Position: Q4 2018 in Review

Concorde Asset Management sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 15,868 shares — an estimated $615K sold.

Concorde Asset Management first reported a position in LMAT in Q2 2017 and held it in 6 quarters. The position peaked at $1.31M in Q3 2017. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

Concorde Asset Management reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
Concorde Asset Management sold 15,868 LeMaitre Vascular shares in Q4 2018, an estimated $615K.
Concorde Asset Management first reported a position in LeMaitre Vascular in Q2 2017 and held it in 6 quarters.
Concorde Asset Management's LeMaitre Vascular position peaked at $1.31M in Q3 2017.
139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Concorde Asset Management's 13F filing for Q4 2018, filed 25 Jan 2019.